MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt flag Egypt · Delayed Price · Currency is EGP
239.09
0.00 (0.00%)
At close: Aug 5, 2025

MINAPHARM Pharmaceuticals Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
2,8171,7962,4081,8221,303987
Upgrade
Market Cap Growth
-25.41%-25.41%32.19%39.82%32.02%-5.49%
Upgrade
Enterprise Value
5,6584,3554,0872,6251,4481,101
Upgrade
Last Close Price
239.09162.36215.89145.12101.7775.10
Upgrade
PE Ratio
16.0214.02-3.092.913.46
Upgrade
PS Ratio
0.450.320.620.500.430.42
Upgrade
PB Ratio
0.620.410.690.600.670.62
Upgrade
P/TBV Ratio
0.730.480.800.700.810.79
Upgrade
P/FCF Ratio
-----3.44
Upgrade
P/OCF Ratio
222.028.1123.533.246.292.26
Upgrade
EV/Sales Ratio
0.900.771.050.730.480.47
Upgrade
EV/EBITDA Ratio
3.843.727.632.421.731.77
Upgrade
EV/EBIT Ratio
4.864.6610.912.721.922.04
Upgrade
EV/FCF Ratio
-6.63----3.84
Upgrade
Debt / Equity Ratio
1.241.241.070.800.640.60
Upgrade
Debt / EBITDA Ratio
4.484.486.672.221.491.54
Upgrade
Debt / FCF Ratio
-----3.34
Upgrade
Asset Turnover
0.550.550.500.660.790.74
Upgrade
Inventory Turnover
3.263.262.792.822.902.73
Upgrade
Quick Ratio
0.790.790.700.870.920.84
Upgrade
Current Ratio
1.251.251.151.461.611.34
Upgrade
Return on Equity (ROE)
4.06%4.06%0.68%25.32%26.86%21.14%
Upgrade
Return on Assets (ROA)
5.64%5.64%3.02%11.05%12.42%10.56%
Upgrade
Return on Capital (ROIC)
6.80%6.80%3.67%13.92%16.41%14.07%
Upgrade
Return on Capital Employed (ROCE)
12.60%12.60%7.20%22.40%28.80%29.10%
Upgrade
Earnings Yield
5.88%8.74%-1.33%33.63%35.79%30.47%
Upgrade
FCF Yield
-30.30%-38.82%-53.66%-32.84%-13.86%29.06%
Upgrade
Dividend Yield
0.52%-0.76%1.93%2.87%3.60%
Upgrade
Payout Ratio
20.67%25.57%-9.43%10.68%29.33%
Upgrade
Buyback Yield / Dilution
--3.57%6.67%--
Upgrade
Total Shareholder Return
0.52%-4.33%8.60%2.87%3.60%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.